Drug development continues to advance understanding about causes of disease, as well as to innovate therapeutic modalities.
Sponsored by:
eBooks
Leveraging Advanced Analytical Tools to De-risk Pharmaceutical Development
Accelerating Small Molecule Advancements
The increasing number of breakthroughs in small molecule drug development are exciting, but corresponding workflows are complex and require much more tailored approaches to ensure successful upstream and downstream processing, drug approvals and commercialization.
On Demand Webinars
CMC Challenges in the Evolving Small Molecule Development Pipeline
A growing proportion of drugs in the development pipeline nowadays start out life at small biotech companies, rather than big pharma businesses.
Environmental Sustainability at Lonza Small Molecules - Wastewater Incineration Reduction
Sustainability is at the forefront of the way Lonza runs its business. Thanks to its Vision Zero initiative, it aspires to reduce emissions, water consumption and waste, as well as work without incidents.
How to Deal with the Complexity of Drugs in Clinical Development
Increasing complexity and tight timelines are putting more pressure on professionals involved in clinical drug development.
Innovative AI-Driven Solutions to Address the Growing Complexity of APIs
The complexity of small molecule active pharmaceutical ingredients (APIs) is rising, bringing longer syntheses that challenge innovators' timely readiness for the Clinic.
White Papers
Secure your place in the IND race with a rapid tox approach
Accelerate Tox Material Delivery and Stay on Track for IND Submission
Al-Enabled Route Scouting Service Technical Brief
Small molecule active pharmaceutical ingredients (APls) are becoming more molecularly complex, resulting in formidable challenges for small and emerging biotechs.
Early Solid Form Screening to Guide Drug Substance Through Drug Product Development
Solid form screening (SFS) encompasses the search, preparation, and characterization necessary to identify, isolate, and ensure confidence in the stability and downstream manufacturability of a lead form. In many ways, this process serves as the bridge between drug substance and drug product for new chemical entities.
Using Synthesis and Route Design Technology to Approach API Complexity
Small molecule active pharmaceutical ingredients (APIs) continue to grow more complex.